Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
CPE CONSULTANTS, LLC
 

Standardized Methodology for Evaluating and Identifying High-Alert Medications-Pharmacist


This session will describe current regulatory requirements surrounding high-alert medications (HAMs) and explain the utilization and implementation of standardized tools to identify and evaluate HAMs to enhance adherence to regulatory standards. It will also discuss how risk reduction strategies can be implemented in the medication use process to prevent harm from HAMs. 
 
Financial Relationship Disclosure Statement – CPE Consultants, LLC
 
All individuals involved in the production of this continuing education program including planners, presenters, reviewers, and/or CPE Consultants, LLC staff with an opportunity to control/influence Continuing Education (CE) content to any degree are required to disclose all relevant financial relationships with “ACCME/ACPE – defined” commercial interests. Furthermore, CPE Consultants, LLC requests all such individuals disclose any potential/possible/probable conflict(s) of interest(s) and all conflicts of interest are resolved prior to the CE activity taking place.  CPE Consultants, LLC staff or associates will disclose complete financial relationship information prior to the beginning of any CE activity.
CPE Consultants, LLC staff, associates and any individual involved in program planning, review and advisory committee members declare no possible or probable conflicts of interest related to this CE activity.
 
 
 

Fee

$10.00

CE Hours

1.00

CE Units

0.100

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

CPE Consultants, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education
Accreditation Council for Pharmacy Education
 

Requirements for CE Credit

After successfully attending this activity and creating your profile, you can complete the evaluation to claim CPE credit.  Complete the evaluation by answering every question.  Do not leave any question unanswered.  If you do not have a comment or do not feel you want to answer the question, please put “NA” in the space provided.  IMPORTANT:  You must complete all the above requirements by 30 DAYS FROM PROGRAM. Failure to do so will result in a loss of Continuing Pharmacy Education Credit.  A system wipeout clears all pending activity into CPE monitoring during this time, so it is imperative that you complete your evaluations within the allotted time frame.  Entering incorrect data will result in a rejection of CPE credit by CPE Monitor.  Carefully check your NABP e-Profile ID and date of birth (MMDD) to ensure this data is accurately recorded!  If you have any questions regarding how to set up your NABP e-Profile and registering for the CPE Monitor service to ensure your CPE units are properly tracked for licensure, visit: http://www.nabp.net/programs/cpe-monitor/cpe-monitor-service/pharmacists.

 

 

 

This session will describe current regulatory requirements surrounding high-alert medications (HAMs) and explain the utilization and implementation of standardized tools to identify and evaluate HAMs to enhance adherence to regulatory standards. It will also discuss how risk reduction strategies can be implemented in the medication use process to prevent harm from HAMs. 

Objectives

  • Describe the current regulatory requirements surrounding high-alert medications
  • Recognize gaps between current safety standards and available published tools for high-alert medications
  • Explain the utilization and implementation of HAMST-R and HAMST-R PRO
  • Discuss how risk reduction strategies can be implemented in the medication use process

Speaker(s)/Author(s)

McKenzie Shenk, PharmD
Assistant Professor of Pharmacy Practice, Cedarville

Activity Number

0864-0000-20-008-H05-P

Release Date: Apr 5, 2020
Credit Expiration Date: Apr 5, 2021

Fee

$10.00

Location

Akron General Hospital